Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 30% ± 10% | |
dendritic cell | 3 studies | 32% ± 14% |
Insufficient scRNA-seq data for expression of UTP3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 1326.82 | 459 / 459 | 100% | 63.08 | 1118 / 1118 |
intestine | 100% | 1571.58 | 966 / 966 | 100% | 50.14 | 527 / 527 |
ovary | 100% | 1090.64 | 180 / 180 | 100% | 37.98 | 430 / 430 |
skin | 100% | 2249.65 | 1809 / 1809 | 100% | 69.00 | 472 / 472 |
esophagus | 100% | 1482.26 | 1444 / 1445 | 100% | 35.98 | 183 / 183 |
kidney | 100% | 1298.75 | 89 / 89 | 100% | 47.03 | 900 / 901 |
thymus | 100% | 1274.06 | 653 / 653 | 100% | 67.84 | 604 / 605 |
bladder | 100% | 1279.86 | 21 / 21 | 100% | 52.71 | 503 / 504 |
uterus | 100% | 1319.18 | 170 / 170 | 100% | 57.25 | 458 / 459 |
liver | 100% | 1188.85 | 226 / 226 | 100% | 31.72 | 405 / 406 |
stomach | 100% | 1361.95 | 358 / 359 | 100% | 42.86 | 286 / 286 |
lung | 100% | 1408.43 | 576 / 578 | 100% | 50.13 | 1155 / 1155 |
prostate | 100% | 1074.48 | 244 / 245 | 100% | 53.35 | 502 / 502 |
adrenal gland | 100% | 1882.48 | 258 / 258 | 99% | 44.07 | 228 / 230 |
brain | 99% | 850.32 | 2619 / 2642 | 100% | 46.92 | 705 / 705 |
pancreas | 97% | 805.59 | 319 / 328 | 100% | 51.36 | 178 / 178 |
adipose | 100% | 1555.46 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 101.27 | 29 / 29 |
spleen | 100% | 3271.66 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 58.20 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 22.91 | 1 / 1 |
blood vessel | 100% | 1121.99 | 1332 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 878.98 | 798 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 42.67 | 79 / 80 |
heart | 96% | 838.89 | 824 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 85% | 1234.15 | 786 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006325 | Biological process | chromatin organization |
GO_0007420 | Biological process | brain development |
GO_0000462 | Biological process | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) |
GO_0042274 | Biological process | ribosomal small subunit biogenesis |
GO_0005730 | Cellular component | nucleolus |
GO_0005634 | Cellular component | nucleus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0032040 | Cellular component | small-subunit processome |
GO_0005515 | Molecular function | protein binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | UTP3 |
Protein name | Something about silencing protein 10 (Charged amino acid-rich leucine zipper 1) (CRL1) (Disrupter of silencing SAS10) (UTP3 homolog) |
Synonyms | CRLZ1 SAS10 |
Description | FUNCTION: Essential for gene silencing: has a role in the structure of silenced chromatin. Plays a role in the developing brain (By similarity). Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding, modifications, rearrangements and cleavage as well as targeted degradation of pre-ribosomal RNA by the RNA exosome . . |
Accessions | Q9NQZ2 ENST00000254803.4 |